Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study
- PMID: 19934327
- PMCID: PMC2955869
- DOI: 10.1158/0008-5472.CAN-09-0648
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study
Abstract
Circadian genes are responsible for maintaining the ancient adaptation of a 24-hour circadian rhythm and influence a variety of cancer-related biological pathways, including the regulation of sex hormone levels. However, few studies have been undertaken to investigate the role of circadian genes in the development of prostate cancer, the most common cancer type among men (excluding nonmelanoma skin cancer). The current genetic association study tested the circadian gene hypothesis in relation to prostate cancer by genotyping a total of 41 tagging and amino acid-altering single nucleotide polymorphisms (SNP) in 10 circadian-related genes in a population-based case-control study of Caucasian men (n = 1,308 cases and 1,266 controls). Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness. Further analyses of haplotypes were consistent with these genotyping results. Findings from this candidate gene association study support the hypothesis of a link between genetic variants in circadian genes and prostate cancer risk, warranting further confirmation and mechanistic investigation of circadian biomarkers in prostate tumorigenesis.
Similar articles
-
Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.BMC Med. 2018 Feb 19;16(1):20. doi: 10.1186/s12916-018-1010-1. BMC Med. 2018. PMID: 29455641 Free PMC article.
-
Circadian pathway genes in relation to glioma risk and outcome.Cancer Causes Control. 2014 Jan;25(1):25-32. doi: 10.1007/s10552-013-0305-y. Epub 2013 Oct 18. Cancer Causes Control. 2014. PMID: 24135790 Free PMC article.
-
Circadian clock genes and risk of fatal prostate cancer.Cancer Causes Control. 2015 Jan;26(1):25-33. doi: 10.1007/s10552-014-0478-z. Epub 2014 Nov 12. Cancer Causes Control. 2015. PMID: 25388799 Free PMC article.
-
An Overview of the Polymorphisms of Circadian Genes Associated With Endocrine Cancer.Front Endocrinol (Lausanne). 2019 Feb 26;10:104. doi: 10.3389/fendo.2019.00104. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30873119 Free PMC article. Review.
-
Circadian gene variants and breast cancer.Cancer Lett. 2017 Apr 1;390:137-145. doi: 10.1016/j.canlet.2017.01.012. Epub 2017 Jan 18. Cancer Lett. 2017. PMID: 28109907 Review.
Cited by
-
Circadian clock protein CRY1 prevents paclitaxel‑induced senescence of bladder cancer cells by promoting p53 degradation.Oncol Rep. 2021 Mar;45(3):1033-1043. doi: 10.3892/or.2020.7914. Epub 2020 Dec 30. Oncol Rep. 2021. PMID: 33650658 Free PMC article.
-
Carcinogenic effects of circadian disruption: an epigenetic viewpoint.Chin J Cancer. 2015 Aug 8;34(9):375-83. doi: 10.1186/s40880-015-0043-5. Chin J Cancer. 2015. PMID: 26253128 Free PMC article.
-
Cancer and the Circadian Clock.Cancer Res. 2019 Aug 1;79(15):3806-3814. doi: 10.1158/0008-5472.CAN-19-0566. Epub 2019 Jul 12. Cancer Res. 2019. PMID: 31300477 Free PMC article. Review.
-
Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci. 2019 May 30;20(11):2662. doi: 10.3390/ijms20112662. Int J Mol Sci. 2019. PMID: 31151182 Free PMC article. Review.
-
Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.Cancer Med. 2019 Apr;8(4):1919-1929. doi: 10.1002/cam4.2050. Epub 2019 Mar 7. Cancer Med. 2019. PMID: 30843665 Free PMC article.
References
-
- Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol. 1987;125:556–561. - PubMed
-
- Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of breast cancer. Faseb J. 1992;6:853–860. - PubMed
-
- Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. The Lancet Oncology. 2007;8:1065–1066. - PubMed
-
- Band PR, Le ND, Fang R, et al. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol. 1996;143:137–143. - PubMed
-
- Irvine D, Davies DM. British Airways flightdeck mortality study, 1950–1992. Aviat Space Environ Med. 1999;70:548–555. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical